Transcriptome analysis for vorinostat-treated choriocarcinoma cells
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE192446
下载链接
链接失效反馈官方服务：
资源简介：
Choriocarcinoma is one of the rare gynecological malignancies with aggressive behavior. Vorinostat is an approved HDAC inhibitor, and HDACs play important roles in regulating gene expression and modulating various cellular processes. Here, the human choriocarcinoma cell lines (JAR and JEG-3) were treated with 1 μM vorinostat or DMSO for 48 h. Then, total RNA was extracted, and transcriptome analysis was performed. RNA sequencing for vorinostat-treated choriocarcinoma cells
创建时间：
2022-10-07
